remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...

(RTTNews) - Axogen, Inc. (AXGN) announced that the U.S. Food and Drug Administration has approved the Biologics License Application (BLA) for AVANCE, an acellular nerve allograft (arwx). AXGN closed ...

ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of ...

Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...

The U.S. FDA granted accelerated approval for the Biologics License Application for Axogen Inc.'s Avance, an acellular nerve allograft that serves as a scaffold for nerve regrowth, for treatment of ...

Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...

Dec 3 (Reuters) - The U.S. Food and Drug Administration has approved Axogen's (AXGN.O), opens new tab nerve repair graft, the health regulator said on Wednesday, paving the way for 12 years of ...

Nov 13, 2025, 12:54 AM IST AvanceTechnologies - Un-Audited Financial Results For The Quarter And Half Year Ended As On 30Th September, 2025. Nov 13, 2025, 12:45 AM IST AvanceTechnologies - Board ...

Barchemy founder and CEO Larry Toscano will retain a significant ownership stake and continue to lead the company Barchemy was founded in 2015 Avance Investment Management has made an investment in ...

Avance Technologies share price has delivered multibagger returns of 3,260% in five years.(Image: Pexel) Avance Technologies share price was locked in at 2% upper circuit of ₹1.68 apiece on the BSE ...

Avance Technologies share price hit upper circuit for the fifth straight trading session to touch a 52-week high on Monday amid heavy buying volumes. The small-cap penny stock gained as much as 2% to ...